195 related articles for article (PubMed ID: 34588773)
1. Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data.
Stöber A; Lutter JI; Schwarzkopf L; Kirsch F; Schramm A; Vogelmeier CF; Leidl R
Int J Chron Obstruct Pulmon Dis; 2021; 16():2637-2651. PubMed ID: 34588773
[TBL] [Abstract][Full Text] [Related]
2. Does uptake of specialty care affect HRQoL development in COPD patients beneficially? A difference-in-difference analysis linking claims and survey data.
Stöber A; Marijic P; Kurz C; Schwarzkopf L; Kirsch F; Schramm A; Leidl R
Eur J Health Econ; 2023 Dec; 24(9):1561-1573. PubMed ID: 36637677
[TBL] [Abstract][Full Text] [Related]
3. Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: A meta-analysis.
Guo J; Chen Y; Zhang W; Tong S; Dong J
Int J Surg; 2020 Jun; 78():28-35. PubMed ID: 32304896
[TBL] [Abstract][Full Text] [Related]
4. The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data.
Huber MB; Kurz C; Kirsch F; Schwarzkopf L; Schramm A; Leidl R
Respir Res; 2020 Nov; 21(1):291. PubMed ID: 33143706
[TBL] [Abstract][Full Text] [Related]
5. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV
Chai CS; Ng DL; Bt Mos S; Ibrahim MAB; Tan SB; Pang YK; Liam CK
BMC Pulm Med; 2023 Apr; 23(1):150. PubMed ID: 37118725
[TBL] [Abstract][Full Text] [Related]
6. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life associates with change in FEV
Lutter JI; Jörres RA; Kahnert K; Schwarzkopf L; Studnicka M; Karrasch S; Schulz H; Vogelmeier CF; Holle R;
BMC Pulm Med; 2020 May; 20(1):148. PubMed ID: 32471493
[TBL] [Abstract][Full Text] [Related]
8. COPD assessment test as a possible tool for evaluating health-related quality of life in lymphangioleiomyomatosis.
Kato M; Kanehiro Y; Yoshimi K; Kodama Y; Sekiya M; Sato T; Takahashi K; Seyama K;
Respir Investig; 2018 Nov; 56(6):480-488. PubMed ID: 30143460
[TBL] [Abstract][Full Text] [Related]
9. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
Solem CT; Sun SX; Sudharshan L; Macahilig C; Katyal M; Gao X
Int J Chron Obstruct Pulmon Dis; 2013; 8():641-52. PubMed ID: 24376348
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.
Aydemir Y; Aydemir Ö; Kalem F
Int J Chron Obstruct Pulmon Dis; 2014; 9():1045-51. PubMed ID: 25298733
[TBL] [Abstract][Full Text] [Related]
11. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
12. Physiological Impairments on Respiratory Oscillometry and Future Exacerbations in Chronic Obstructive Pulmonary Disease Patients without a History of Frequent Exacerbations.
Zhang Y; Tanabe N; Shima H; Shiraisi Y; Oguma T; Sato A; Muro S; Sato S; Hirai T
COPD; 2022; 19(1):149-157. PubMed ID: 35392737
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
Janjua S; Fortescue R; Poole P
Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
15. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H; Htet A; Moe S
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
17. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
18. The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline.
Kerkhof M; Voorham J; Dorinsky P; Cabrera C; Darken P; Kocks JWH; Sadatsafavi M; Sin DD; Carter V; Price DB
Int J Chron Obstruct Pulmon Dis; 2020; 15():1909-1918. PubMed ID: 32821093
[TBL] [Abstract][Full Text] [Related]
19. Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.
Bae E; Choi SE; Lee H; Shin G; Kang D
BMC Pulm Med; 2020 Mar; 20(1):73. PubMed ID: 32293387
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset.
Calverley PMA; Papi A; Page C; Rogliani P; Dal Negro RW; Cazzola M; Cicero AF; Wedzicha JA
Int J Chron Obstruct Pulmon Dis; 2022; 17():1909-1920. PubMed ID: 36034589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
